More patient education about cholinesterase inhibitor drugs may help Alzheimer's disease patients with lower education levels stick with their medication regimens, University of Saskatchewan researchers reported at the Alzheimer's Disease International 28th International Conference. The study found people with less formal education were more likely to stop taking the drugs, suggesting that if clinicians spend more time explaining what to expect from the medication it could improve compliance.

Related Summaries